Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Early research (Phase 1)UnknownNCT06551233
What this trial is testing

Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Early research (Phase 1)Study completedNCT01458847
What this trial is testing

Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
BioCis Pharma Ltd 12
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Looking for participantsNCT06263153
What this trial is testing

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Who this might be right for
Bladder Urothelial CarcinomaMuscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more
Yuanquan Yang 24
Not applicableStudy completedNCT03591367
What this trial is testing

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

Who this might be right for
Bladder CancerBladder DiseaseBladder Neoplasm+1 more
Mansoura University 115
Not applicableEnded earlyNCT02145390
What this trial is testing

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Bladder CancerBladder CarcinomaTransition Cell Cancer+1 more
University of Miami 1
Testing effectiveness (Phase 2)Ended earlyNCT01625260
What this trial is testing

ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Altor BioScience 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Not applicableUnknownNCT04966130
What this trial is testing

Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 96
Not applicableUnknownNCT05671900
What this trial is testing

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Clinical Hospital Centre Zagreb 70
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Early research (Phase 1)Study completedNCT06100653
What this trial is testing

BCG for Therapeutic Use Phase I Clinical Trial

Who this might be right for
Non-muscular Invasive Bladder Cancer
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 10
Testing effectiveness (Phase 2)WithdrawnNCT04040725
What this trial is testing

Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression

Who this might be right for
Bladder Cancer
Dana-Farber Cancer Institute
Early research (Phase 1)Study completedNCT02722538
What this trial is testing

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

Who this might be right for
Urinary Bladder Cancer
Taris Biomedical LLC 23
Not applicableLooking for participantsNCT07390617
What this trial is testing

Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

Who this might be right for
NeuropathyUrothelial CarcinomaMetastatic Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 50
Not applicableActive Not RecruitingNCT07511517
What this trial is testing

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell, Bladder
Oslo University Hospital 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04917809
What this trial is testing

Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Who this might be right for
Bladder CancerRecurrent Bladder CancerFGFR3 Gene Mutation
Memorial Sloan Kettering Cancer Center 20
Not applicableAvailableNCT06810141
What this trial is testing

ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer

Who this might be right for
NMIBC
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT07505615
What this trial is testing

A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

Who this might be right for
NMIBC
Ding-Wei Ye 20
Next Page